Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Nextech3D.ai Announces First New Customer Win For its AI Powered Photography Studio (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Tempus AI Inc TEM

Healthcare Biotechnology
Tempus AI, Inc. is a technology company. The Company provides next generation diagnostics across multiple disease areas, with technology capabilities, harnessing the data and analytics to help personalize medicine. The Company’s product lines include genomics, data, and artificial intelligence applications (AI). Its genomics product line leverages its laboratories to provide next generation sequencing, diagnostics, polymerase chain reaction (PCR), profiling, molecular genotyping, and other anatomic and molecular pathology testing. The Company's AI applications are focused on developing and providing diagnostics that are algorithmic in nature, implementing new software as a medical device, and building and deploying clinical decision support tools. Its primary product of AI applications is Next, an AI platform that leverages machine learning to apply an intelligent layer onto routinely generated data to proactively identify and minimize care gaps for oncology and cardiology patients.


NDAQ:TEM - Post by User

Tempus AI Inc
<< Previous
 Bullboard Posts
User Avatar Image
(306)
•••
Post by whytestockson Jan 23, 2025 11:45am
19 Views
Post# 36417131

Tempus AI Stock Is Up 40% in January. Is It Too Late to Buy?

Tempus AI Stock Is Up 40% in January. Is It Too Late to Buy?
NEWS: $TEM Tempus AI Stock Is Up 40% in January. Is It Too Late to Buy?2025-01-23 10:28:13 ET In this video, I will talk about Tempus AI (NASDAQ: TEM) , why the stock has soared recently, and if it is worth chasing. Watch the short video to learn more, consider subscribing, and click the special offer link below. *Stock prices used were from the ...TEM - Tempus AI Stock Is Up 40% in January. Is It Too Late to Buy?

<< Previous
 Bullboard Posts
Dealroom for high-potential pre-IPO opportunities